Envisioning Future Urinary Tract Infection Diagnostics

Robin Patel; Christopher R. Polage; Jennifer Dien Bard; Larissa May; Francesca M. Lee; Valeria Fabre; Mary K. Hayden; Sarah D.B. Doernberg; David A. Haake; Barbara W. Trautner; Larissa Grigoryan; Ephraim L. Tsalik; Kimberly E. Hanson

doi:10.1093/cid/ciab749

Envisioning Future Urinary Tract Infection Diagnostics

Robin Patel, Christopher R. Polage, Jennifer Dien Bard, Larissa May, Francesca M. Lee, Valeria Fabre, Mary K. Hayden, Sarah D.B. Doernberg, David A. Haake, Barbara W. Trautner, Larissa Grigoryan, Ephraim L. Tsalik, Kimberly E. Hanson

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Urinary tract infections (UTIs) are among the most common bacterial infections in the United States and are a major driver of antibiotic use, both appropriate and inappropriate, across healthcare settings. Novel UTI diagnostics are a strategy that might enable better UTI treatment. Members of the Antibacterial Resistance Leadership Group Laboratory Center and the Infectious Diseases Society of America Diagnostics Committee convened to envision ideal future UTI diagnostics, with a view towards improving delivery of healthcare, patient outcomes and experiences, and antibiotic use, addressing which types of UTI diagnostics are needed and how companies might approach development of novel UTI diagnostics.

Original language	English (US)
Pages (from-to)	1284-1292
Number of pages	9
Journal	Clinical Infectious Diseases
Volume	74
Issue number	7
DOIs	https://doi.org/10.1093/cid/ciab749
State	Published - Apr 1 2022

Keywords

diagnostics
laboratory diagnosis
urinary tract infection
UTI

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1093/cid/ciab749

Cite this

@article{206d1d2f58b74361acdd85aa63d84e38,

title = "Envisioning Future Urinary Tract Infection Diagnostics",

abstract = "Urinary tract infections (UTIs) are among the most common bacterial infections in the United States and are a major driver of antibiotic use, both appropriate and inappropriate, across healthcare settings. Novel UTI diagnostics are a strategy that might enable better UTI treatment. Members of the Antibacterial Resistance Leadership Group Laboratory Center and the Infectious Diseases Society of America Diagnostics Committee convened to envision ideal future UTI diagnostics, with a view towards improving delivery of healthcare, patient outcomes and experiences, and antibiotic use, addressing which types of UTI diagnostics are needed and how companies might approach development of novel UTI diagnostics.",

keywords = "diagnostics, laboratory diagnosis, urinary tract infection, UTI",

author = "Robin Patel and Polage, {Christopher R.} and {Dien Bard}, Jennifer and Larissa May and Lee, {Francesca M.} and Valeria Fabre and Hayden, {Mary K.} and Doernberg, {Sarah D.B.} and Haake, {David A.} and Trautner, {Barbara W.} and Larissa Grigoryan and Tsalik, {Ephraim L.} and Hanson, {Kimberly E.}",

year = "2022",

month = apr,

day = "1",

doi = "10.1093/cid/ciab749",

language = "English (US)",

volume = "74",

pages = "1284--1292",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "7",

}

TY - JOUR

T1 - Envisioning Future Urinary Tract Infection Diagnostics

AU - Patel, Robin

AU - Polage, Christopher R.

AU - Dien Bard, Jennifer

AU - May, Larissa

AU - Lee, Francesca M.

AU - Fabre, Valeria

AU - Hayden, Mary K.

AU - Doernberg, Sarah D.B.

AU - Haake, David A.

AU - Trautner, Barbara W.

AU - Grigoryan, Larissa

AU - Tsalik, Ephraim L.

AU - Hanson, Kimberly E.

PY - 2022/4/1

Y1 - 2022/4/1

N2 - Urinary tract infections (UTIs) are among the most common bacterial infections in the United States and are a major driver of antibiotic use, both appropriate and inappropriate, across healthcare settings. Novel UTI diagnostics are a strategy that might enable better UTI treatment. Members of the Antibacterial Resistance Leadership Group Laboratory Center and the Infectious Diseases Society of America Diagnostics Committee convened to envision ideal future UTI diagnostics, with a view towards improving delivery of healthcare, patient outcomes and experiences, and antibiotic use, addressing which types of UTI diagnostics are needed and how companies might approach development of novel UTI diagnostics.

AB - Urinary tract infections (UTIs) are among the most common bacterial infections in the United States and are a major driver of antibiotic use, both appropriate and inappropriate, across healthcare settings. Novel UTI diagnostics are a strategy that might enable better UTI treatment. Members of the Antibacterial Resistance Leadership Group Laboratory Center and the Infectious Diseases Society of America Diagnostics Committee convened to envision ideal future UTI diagnostics, with a view towards improving delivery of healthcare, patient outcomes and experiences, and antibiotic use, addressing which types of UTI diagnostics are needed and how companies might approach development of novel UTI diagnostics.

KW - diagnostics

KW - laboratory diagnosis

KW - urinary tract infection

KW - UTI

UR - http://www.scopus.com/inward/record.url?scp=85128488298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85128488298&partnerID=8YFLogxK

U2 - 10.1093/cid/ciab749

DO - 10.1093/cid/ciab749

M3 - Article

C2 - 34463708

AN - SCOPUS:85128488298

SN - 1058-4838

VL - 74

SP - 1284

EP - 1292

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 7

ER -

Envisioning Future Urinary Tract Infection Diagnostics

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this